ArticleCureus2023
Intraoperative Fibrinous Reaction During Phacoemulsification With Posterior Chamber Intraocular Lens Implantation.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a case report of a 67-year-old female who underwent phacoemulsification and posterior chamber intraocular lens (IOL) implantation and developed a rare fibrinous reaction intraoperatively. During surgery, the patient experienced poor dilation and iris tissue prolapse. Phacoemulsification and IOL insertion into the capsular bag were performed. A fibrinous reaction was noticed at the end of surgery and was managed excellently with triamcinolone. Postoperatively, the patient achieved visual acuity of 20/20, with no flare or fibrinous reaction observed on slit lamp examination. This case report highlights the possible related mechanisms of such an event, as well as clinical management and response to treatment. To reduce the risk of complications, close follow-up and prompt initiation of anti-inflammatory therapy are essential. Further studies are needed to investigate the predisposing factors for developing fibrinous reactions during cataract extraction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.